The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists with a comprehensive update on state-of-the-art therapeutic strategies and ongoing research.

Scheduled for March 6–7, 2026, in Zurich, Switzerland, the course focuses on multidisciplinary care, evidence-based management, and the interpretation of novel translational research, including molecular profiling and clinical trials.

Led by co-chairs Viktor Gruenwald and Bernadett Szabados, the program offers successful applicants complimentary registration, accommodation, and a travel grant, emphasizing ESMO’s commitment to advancing professional expertise in bladder cancer treatment.

Application.